通过针对线粒体的近红外光动力疗法放大抗瘤免疫反应
Cheng-Ao Li1,2, Junjie Nan3, Qingxuan Ye3
1State Key Laboratory of Silicon and Advanced Semiconductor Materials, Institute for Composites Science Innovation, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310058, China.
概括
这项研究引入了一种用于近红外光激活光动力疗法 (PDT) 的新型纳米平台. 它通过向线粒体并触发免疫细胞死亡来增强抗瘤免疫力,改善深层瘤治疗并防止复发.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 支持炎症的光动力学疗法 (PDT) 显示出对全身抗瘤免疫的前景.
- 有限的紫外线可见光透和瘤缺氧阻碍了传统PDT的疗效.
- 需要新的策略来克服这些局限性,以改善癌症治疗.
研究的目的:
- 开发一种针对线粒体的纳米平台,用于近红外 (NIR) 光激活的PDT.
- 增强全身抗瘤免疫力,克服深层瘤和缺氧的挑战.
- 为了提高免疫检查点阻塞 (ICB) 疗法的疗效.
主要方法:
- 一个针对线粒体的纳米平台 (NZ@TG) 设计用于NIR激活的PDT.
- 该纳米平台利用兰化物有机三重组光传感用于局部氧化损伤.
- PDT诱导的缺氧激活TH302前药物,导致细胞循环停止和免疫细胞死亡 (ICD).
主要成果:
- 该纳米平台在正确的肝脏瘤模型中的深层病变中展示了增强的瘤切除.
- 它成功触发了ICD,释放了与损伤相关的分子模式 (DAMPs) 来激活免疫反应.
- 诱导了显著的长期抗瘤免疫记忆,改善了ICB治疗的疗效.
结论:
- 开发的NIR-PDT纳米平台有效地解决了针对深层瘤的传统PDT的局限性.
- 这种策略强烈地激活了抗瘤免疫力,为癌症治疗提供了有前途的方法.
- 这种方法有可能预防瘤复发并增强组合疗法.
更多相关视频
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.2K
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
7.9K
相关概念视频
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
01:46Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K